Recombinant Vector Shedding

Recombinant Vector Shedding is the release and potential transmission of genetically engineered viral or non-viral delivery systems used in gene therapy from a treated individual into the environment or to other organisms, distinguishing it from endogenous viral shedding by involving exogenous, artificially constructed vectors.

4

Publications

288

Citations

46

Authors

17

Institutions

Publications per year

2017–2026

0

Authors

46

  1. CL
    Caroline Le Guiner

    Inserm, France

    1 publications · 17 citations

    1

    h-index

  2. CO
    Cristina Olagüe

    Universidad de Navarra, Spain

    1 publications · 61 citations

    1

    h-index

  3. RF
    Roberto Ferrero

    Universidad de Navarra, Spain

    1 publications · 61 citations

    1

    h-index

  4. FB
    Fabrizio Benedicenti

    The San Raffaele Telethon Institute for Gene Therapy, Italy

    1 publications · 14 citations

    1

    h-index

  5. JJ
    Juán José Gavira

    Clinica Universidad de Navarra, Spain

    1 publications · 61 citations

    1

    h-index

1–5 of 46

Venues

  1. Molecular Therapy

    1 publications · 196 citations

    1

    h-index

  2. Methods in molecular biology

    Book series · 1 publications · 17 citations

    1

    h-index

  3. Gene Therapy

    1 publications · 14 citations

    1

    h-index

  4. Human Gene Therapy

    1 publications · 61 citations

    1

    h-index

1–4